MedTrace Logo

Post-Surgery Extracorporeal Life Support

NCT04330651 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-04-28

No results posted yet for this study

Summary

Extracorporeal Life Support (ECLS) may provide pulmonary and circulatory support for patients with acute heart failure refractory to conventional medical therapy. However, indications and effectiveness of ECLS engagement post-surgery remains a concern. The investigators sought to analyze indications, modality and outcomes of PS-ECLS, to identify predictors of early and midterm survival after PS-ECLS. The investigators have recorded prospectively, and analysed data of 209 consecutive PS-ECLS patients between January 2004 and December 2018. Demographic and clinical data before, during and after PS-ECLS were collected and their influence on hospital mortality and outcomes (early and midterm) will analyse. Multivariate analysis of pre PS-ECLS implantation factors (as age, female sex , insulin-dependent diabetes, pulmonary hypertension, STS, type of surgical procedure data, pre-ECLS blood lactate level) will be made for identify prognostic risk factors of in-hospital mortality. Overall survival will be analysed, at 6 months,1-year and 5-years, respectively and the factors influencing mild/term outcome will be investigated.

Conditions

  • Cardiogenic Shock
  • Extracorporeal Life Support
  • Extracorporeal Membrane Oxygenation Complication
  • Post Cardiac Arrest Syndrome
  • Post-cardiac Surgery

Interventions

PROCEDURE

ECLS

Emergency application of Extracorporeal Life Support in post-surgical patients

Sponsors & Collaborators

  • Sandro Gelsomino

    collaborator UNKNOWN

  • Edvin Prifti

    collaborator UNKNOWN

  • Francesco Cabrucci

    collaborator UNKNOWN

  • Marco Bugetti

    collaborator UNKNOWN

  • Orlando Parise

    collaborator UNKNOWN

  • Aleksander Dokollari

    collaborator UNKNOWN

  • University of Florence

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2021-03-19
Completion
2029-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04330651 on ClinicalTrials.gov